HUAYUNOL
Live / Allowed — Approved for publication (as of 28 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99263723
- Mark type
- Word mark
- Filed
- 02 Jul 2025
- Attorney of record
- Kayleigh A. Hartwig
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; Medicinal preparations for the treatment of cancer, viral diseases and infectious diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of hepatitis; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral diseases; Anti-inflammatories; Tumor suppressing agents; Pharmaceutical preparations, namely, antivirals; all of the foregoing available only by prescription
Owner
- Huahui Health Ltd., Beijing, CN
Prosecution history
- 28 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Mar 2026 — ASSIGNED TO LIE
- 13 Mar 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 11 Mar 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 11 Mar 2026 — LETTER OF SUSPENSION E-MAILED
- 11 Mar 2026 — SUSPENSION LETTER WRITTEN
- 10 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Nov 2025 — NON-FINAL ACTION E-MAILED
- 24 Nov 2025 — NON-FINAL ACTION WRITTEN
- 19 Nov 2025 — ASSIGNED TO EXAMINER